Patient prognosis is related to a number of factors.
(age: survival is higher in those younger than 50 years).
Gender: higher survival rate in females.
pathological staging: best prognosis for the lymphocyte-dominant type, worst prognosis for the lymphocyte-cutting type
Staging: better prognosis for early treatment, relatively poor prognosis for late treatment.